Investors
Key press releases
Key upcoming events
Key corporate presentations
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the NYSE Alternext market (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$27.0600
+0.2100 (0.7821%)
- Prev. close
- 26.8500
- Volume
- 50,514
- High
- 27.0600
- Capitalization
- 1.148B
Cellectis (Alternext)
Ticker: ALCLS
€23.3200
+0.2600 (1.1275%)
- Prev. close
- 23.0600
- Volume
- 46,076
- High
- 23.5000
- Capitalization
- 981.899M
Cellectis contact information
Investor relations USA
Simon Harnest
+1 646 385 9008
Investor relations Europe
Victor Chaulot-Talmon
+33 (0)1 81 69 17 22
Citibank ADR contact information
Sales Desk - New York
Jason Zoppel
Michael O’Leary
Scott H. Pollak
+1-212-723-5435
Sales Desk - London
Michael Woods
+44-207-500-2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89
Transaction and share inquiries
Covering research analysts
Bryan Garnier – Marion Levi
Citi - Robyn Karnauskas
Jefferies – Biren Amin
Jones Trading - Soumit Roy
Ladenburg – Wangzhi Li
Nomura – Chris Marai
Oppenheimer – Hartaj Singh
Portzamparc –
Suntrust Robinson – Peter Lawson
Wells Fargo – Jim Birchenough